2010•The Journal of Medical Theory and PracticeRequires access

Clinical Evaluation of Edaravone Combined with Sodium Ozagrel on Treating Progressive Cerebral Infarction

Zhang Hai-ya

Open publisher page 0 citations

Abstract

Objective:To observe the curative effects of Edaravone combined with Sodium ozagrel on treating progressive cerebral infarction(PCI).Methods:120 patients with PCI were randomly divided into two groups.Treatment group(60 patients) was treated with Edaravone 30 mg iv dirp bid for 14 days,and Sodium ozagrel 80mg iv drip bid for 14 days.Control group(60 patients)was treated with Sodium ozagrel only,whose usage was the same as that of treatment group.Therapeutic effect was evaluated by clinical efficacy.Results:The total effective rate(88.3%)of the treatment group was obviously higher than that of the control group(70%).Conclusion:Treatment of Edaravone combined with Sodium ozagrel can safely improve the symptom of PCI patients.

About this research paper

What this paper is about

Objective:To observe the curative effects of Edaravone combined with Sodium ozagrel on treating progressive cerebral infarction(PCI).Methods:120 patients with PCI were randomly divided into two groups.Treatment group(60 patients) was treated with Edaravone 30 mg iv dirp bid for 14 days,and Sodium ozagrel 80mg iv drip bid for 14 days.Control group(60 patients)was treated with Sodium ozagrel only,whose usage was the same as that of treatment group.Therapeutic effect was evaluated by clinical efficacy.Results:The total effective rate(88.3%)of the treatment group was obviously higher than that of the control group(70%).Conclusion:Treatment of Edaravone combined with Sodium ozagrel can safely improve the symptom of PCI patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the curative effects of Edaravone combined with Sodium ozagrel on treating progressive cerebral infarction(PCI).Methods:120 patients with PCI were randomly divided into two groups.Treatment group(60 patients) was treated with Edaravone 30 mg iv dirp bid for 14 days,and Sodium ozagrel 80mg iv drip bid for 14 days.Control group(60 patients)was treated with Sodium ozagrel only,whose usage was the same as that of treatment group.Therapeutic effect was evaluated by clinical efficacy.Results:The total effective rate(88.3%)of the treatment group was obviously higher than that of the control group(70%).Conclusion:Treatment of Edaravone combined with Sodium ozagrel can safely improve the symptom of PCI patients.

Key concepts: Edaravone, Medicine, Conventional PCI, Clinical efficacy, Anesthesia, Therapeutic effect, Sodium, Cerebral infarction

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Evaluation of Edaravone Combined with Sodium Ozagrel on Treating Progressive Cerebral Infarction — Research Paper | ScholarLens